Identification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline Myopathy
- PMID: 24268659
- PMCID: PMC3852928
- DOI: 10.1016/j.ajhg.2013.10.020
Identification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline Myopathy
Abstract
Nemaline myopathy (NM) is a rare congenital muscle disorder primarily affecting skeletal muscles that results in neonatal death in severe cases as a result of associated respiratory insufficiency. NM is thought to be a disease of sarcomeric thin filaments as six of eight known genes whose mutation can cause NM encode components of that structure, however, recent discoveries of mutations in non-thin filament genes has called this model in question. We performed whole-exome sequencing and have identified recessive small deletions and missense changes in the Kelch-like family member 41 gene (KLHL41) in four individuals from unrelated NM families. Sanger sequencing of 116 unrelated individuals with NM identified compound heterozygous changes in KLHL41 in a fifth family. Mutations in KLHL41 showed a clear phenotype-genotype correlation: Frameshift mutations resulted in severe phenotypes with neonatal death, whereas missense changes resulted in impaired motor function with survival into late childhood and/or early adulthood. Functional studies in zebrafish showed that loss of Klhl41 results in highly diminished motor function and myofibrillar disorganization, with nemaline body formation, the pathological hallmark of NM. These studies expand the genetic heterogeneity of NM and implicate a critical role of BTB-Kelch family members in maintenance of sarcomeric integrity in NM.
Copyright © 2013 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Wallgren-Pettersson C., Sewry C.A., Nowak K.J., Laing N.G. Nemaline myopathies. Semin. Pediatr. Neurol. 2011;18:230–238. - PubMed
-
- Ryan M.M., Schnell C., Strickland C.D., Shield L.K., Morgan G., Iannaccone S.T., Laing N.G., Beggs A.H., North K.N. Nemaline myopathy: a clinical study of 143 cases. Ann. Neurol. 2001;50:312–320. - PubMed
-
- Wallgren-Pettersson C. Nemaline and myotubular myopathies. Semin. Pediatr. Neurol. 2002;9:132–144. - PubMed
-
- Sewry C.A. Pathological defects in congenital myopathies. J. Muscle Res. Cell Motil. 2008;29:231–238. - PubMed
-
- Hutchinson D.O., Charlton A., Laing N.G., Ilkovski B., North K.N. Autosomal dominant nemaline myopathy with intranuclear rods due to mutation of the skeletal muscle ACTA1 gene: clinical and pathological variability within a kindred. Neuromuscul. Disord. 2006;16:113–121. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
